Oct 3, 2026

Featuring an interview with Dr Neeraj Agarwal, including the following topics:

• Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00)
• Approaches to monitoring for disease progression in patients who are PTEN deficient; prognostic significance and implications for testing...

Oct 2, 2026

Featuring a slide presentation and related discussion from Dr Neeraj Agarwal, including the following topics:

• Therapeutic targets of systemic therapy in prostate cancer (0:00)
• Prevalence of genomic alterations in prostate cancer including PTEN deficiency; prognostic and predictive value (3:52)
• Optimal timing...

Sep 16, 2026

Featuring perspectives from Dr Alexandra Drakaki, including the following topics:

• Case: A man in his late 70s with diabetes and metastatic bladder cancer achieves radiographic response with enfortumab vedotin (EV) and pembrolizumab but develops uncontrolled hyperglycemia (0:00)
• Case: A man in his early 70s with...

Sep 16, 2026

Featuring perspectives from Dr Alexandra Drakaki, including the following topics:

• Case: A man in his early 80s with bladder cancer and metastatic progression in the viscera and lymph nodes receives enfortumab vedotin (EV) with pembrolizumab — Part 1 (0:00)
• Case: A man in his early 80s with metastatic bladder...

Sep 8, 2026

Featuring perspectives from Dr William K Oh and Dr Mary-Ellen Taplin, including the following topics:

• Introduction: Another Perspective on the Treatment of Localized Prostate Cancer (0:00)
• Nonmetastatic Disease (10:32)
• Metastatic Androgen Pathway Modulation-Naïve and Androgen Pathway Modulation-Sensitive Disease...